V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Warby Parker Executive Compensation (FY25)

WRBY · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Neil Blumenthal
Latest say-on-pay support
=
June 8, 2026
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.

The Warby Parker brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
Data as of October 22, 2026Latest filing (8-K): June 12, 2026
7 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Warby Parker brief$1,500Get the executive brief
Velarion Member, one year
147 figures on this page: 144 cited to the filing that reported them, 3 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Neil Blumenthal: $1,476,151 → $9,000,180

Frequently asked questions

Answers drawn from the data on this page.
Who is Warby Parker's chief executive and what were they paid?
Neil Blumenthal was paid $9,000,180 in total compensation as Co-Chief Executive Officer and Director for fiscal 2025. Compared with the $1,476,151 reported for fiscal 2024, Blumenthal's total was up.
What was Warby Parker's say-on-pay result?
The say-on-pay proposal drew 96.0% support at the meeting held June 8, 2026 for fiscal 2025.
Which companies are in Warby Parker's peer group?
The disclosed peer group names Angi Inc., Arhaus, Inc., Bausch + Lomb Corporation, Bumble Inc. and Canada Goose Inc., among others.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Neil Blumenthal
Co-CEO and Director
◇———◇—◇◇
Dave Gilboa
Co-CEO and Director
◇———◇—◇◇
Steven Miller
CFO
◇———◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Steven Miller
Former CFO
◇—◇—◇—◇◇
Neil Blumenthal
Co-CEO and Director
◇———◇—◇◇
Dave Gilboa
Co-CEO and Director
◇———◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Steven Miller
CFO
◇—◇———◇◇
Neil Blumenthal
Co-CEO and Director
◇—◇———◇◇
Dave Gilboa
Co-CEO and Director
◇—◇———◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Neil Blumenthal
Co-Chief Executive Officer and Director
◇—◇———◇◇
Dave Gilboa
Co-Chief Executive Officer and Director
◇—◇———◇◇
Steven Miller
Former Senior Vice President, Chief Financial Officer and Treasurer
Departed during or after this year
◇—◇———◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Dave GilboaRSU◇——◇——◇
Dave GilboaRSU◇——◇——◇
Dave GilboaPSU◇◇◇—◇—◇
Dave GilboaRSU◇——◇——◇
Neil BlumenthalRSU◇——◇——◇
Neil BlumenthalRSU◇——◇——◇
Neil BlumenthalRSU◇——◇——◇
Neil BlumenthalPSU◇◇◇—◇—◇
Steven MillerRSU◇——◇——◇
Steven MillerRSU◇——◇——◇
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Dave GilboaOption◇—◇2/21/2027
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
Neil BlumenthalOption◇—◇2/21/2027
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
Steven MillerOption◇—◇1/27/2031
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Steven Miller
Former Senior Vice President, Chief Financial Officer and Treasurer · Terms as described in the company’s compensation discussion · citing a 2025 filing
Severance multiple◇
Severance base◇
Change-in-control trigger◇
Equity acceleration on change in control◇
Benefits continuation◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Ronald Williams
Lead independent director
◇◇————◇
Teresa Briggs
◇◇————◇
Andrew Hunt
◇◇————◇
Bradley Singer
◇◇————◇
Youngme Moon
◇◇————◇
Jeffrey Raider
◇◇————◇
Dave Gilboa, Neil Blumenthal and Joel Cutler served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Lead independent director premium◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Angi Inc. ANGI
  • Arhaus, Inc. ARHS
  • Bausch + Lomb Corporation BLCO
  • Bumble Inc. BMBL
  • Canada Goose Inc. GOOS
  • CarGurus Inc. CARG
  • Evolent Health Inc. EVH
  • FIGS, Inc. FIGS
  • Five Below Inc. FIVE
  • GoodRx Holdings, Inc. GDRX
  • Him & Hers Health, Inc. symbol not shown
  • National Vision Holdings Inc. EYE
  • Olaplex Holdings, Inc. OLPX
  • Progyny Inc. PGNY
  • Revolve Group Inc. RVLV
  • Teladoc Health, Inc. TDOC
  • YETI Holdings, Inc. YETI

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 8, 2026=◇◇◇
2024June 10, 2025=◇◇◇
2023June 7, 2024=◇◇◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Dave Gilboa (Co-Chief Executive Officer and Director), FY2025 total compensation $8,997,680 (base salary $575,000) [exec_comp, SEC accession 0001104659-26-050432, filed 2026-04-28]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Warby Parker files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Warby Parker disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Warby Parker sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Warby Parker's disclosed peer group is defensible, who names Warby Parker back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
147 figures on this page: 144 cited to the filing that reported them, 3 calculated from figures it prints.
144 cited to the filing
3 calculated from the filing

Documents cited

  1. 0001504776-26-000013
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001104659-26-050432
    2025 Summary Compensation Table · DIRECTOR COMPENSATION
  3. 0001104659-25-059495
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001104659-25-040245
    Compensation Discussion and Analysis · EXECUTIVE COMPENSATION TABLES
  5. 0001104659-24-070919
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001104659-23-051477
    2022 Summary Compensation Table
  7. 0001104659-24-052050
    2023 Summary Compensation Table
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Warby Parker executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/WRBY (accessed 2026).
Short form: data: Velarion

The Warby Parker brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
7 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Warby Parker and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Warby Parker discloses

The companies named in WRBY's own disclosed peer group.

Angi Inc.Arhaus, Inc.Bausch + Lomb CorporationBumble Inc.CarGurus Inc.Evolent Health Inc.FIGS, Inc.Five Below Inc.GoodRx Holdings, Inc.National Vision Holdings Inc.Olaplex Holdings, Inc.Progyny Inc.Revolve Group Inc.Teladoc Health, Inc.YETI Holdings, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy